In a recent study presented at the American Academy of Dermatology’s annual meeting, researchers examined the efficacy of various doses of an oral JAK1/JAK2 inhibitor for treating patients with...
In a post-hoc analysis of the ALLEGRO phase 2b/3 trial, researchers evaluated whether scalp, eyebrow, and eyelash hair regrowth would continue over 48 weeks in patients with alopecia areata treated with...
Researchers evaluated the efficacy of Janus kinase inhibitors in adult patients with alopecia areata. Their research was presented at the American Academy of Dermatology’s 2023 annual meeting in New...
In a recent study presented at the American Academy of Dermatology’s 2023 annual meeting, researchers examined the relationship between scalp hair loss severity and baseline distribution of eyebrow and...
Despite the availability of several treatments for hyperhidrosis—a condition that can have significant psychiatric and social effects—half of the 15 million US patients with this condition do not seek...
Research presented at the 2019 American Academy of Dermatology Summer Meeting indicates that US melanoma rates and UV exposure have skyrocketed over the past several decades, especially among young white...
Researchers recently aimed to explore the potential relationship between hyperhidrosis and mental health conditions including ADD, depression, and anxiety. The findings were presented at the 2019 AAD Annual...
A growing body of evidence suggests that several sessions of a 10-minute procedure may be beneficial for certain patients with hair loss, including those with hereditary hair thinning or baldness. The...
New research sheds light on whether the acne drug isotretinoin plays a role in developing depression. The findings were presented at the 2019 AAD Annual Meeting.
